RSS   Newsletter   Contact   Advertise with us

Therachon appoints Maarten Kraan as CMO

Staff Writer | Basel, Switzerland | March 22, 2017
Maarten KraanMarch 22, 2017, Basel, Switzerland - Therachon, a biotechnology company, announced it has appointed Maarten Kraan to the role of chief medical officer.
Most recently, Dr. Kraan was Senior Vice President, Head of Innovative Medicines Respiratory and Inflammation at AstraZeneca.

Prior to that, Dr. Kraan was Vice President, Head of Clinical Research and Experimental Development Inflammation at Hoffman La Roche.

Before that, he was Vice President, Immunosciences at Bristol Myers Squibb.

Dr. Kraan began his pharmaceutical career at Schering Plough, holding roles of increasing responsibility, including Senior Global Medical Director Immunology, Global Medical Affairs.

He currently serves as an Adjunct Professor at Goteborg University (Sweden).

Dr. Kraan held numerous academic, editorial and hospital positions before entering the pharmaceutical industry.

He received his Ph.D. in immunology and M.D. from Leiden University (Netherlands).